Lung Surfactants for Neonatal Respiratory Distress Syndrome: Animal-Derived or Synthetic Agents?

Author： Suresh G.K.   Soll R.F.  

Publisher： Adis International

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.4, Iss.8, 2002-01, pp. : 485-492

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Risk-Benefit Assessment of Natural and Synthetic Exogenous Surfactants in the Management of Neonatal Respiratory Distress Syndrome

By Walti H.   Monset-Couchard M.  

Drug Safety, Vol. 18, Iss. 5, 1998-05 ,pp. : 321-337

Adis International

Access to resources Recommend Favorite

Anaesthetic-Related Neuroprotection: Intravenous or Inhalational Agents?

By Schifilliti Daniela  

CNS Drugs, Vol. 24, Iss. 11, 2010-11 ,pp. : 893-907

Adis International

Access to resources Recommend Favorite

PAR2 antagonists: anti-inflammatory agents?

By  

Inpharma, Vol. 1, Iss. 1226, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Can statins operate as neuroprotective agents?

By  

Inpharma, Vol. 1, Iss. 1305, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Lucinactant in neonatal respiratory distress syndrome: profile report

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 10, 2005-10 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite